Company Filing History:
19 out of 44 
9 out of 44 
2 out of 5 Years Active: 2011-2022
Title: Richland Wayne Tester – Innovator in Kinase Inhibitors
Introduction
Richland Wayne Tester, based in Marlborough, MA, is a prominent inventor with a remarkable portfolio of 30 patents. His contributions to the field of pharmaceutical sciences, particularly in developing kinase inhibitors, have significantly advanced medical research and treatment methodologies.
Latest Patents
Among his latest innovations are two notable patents:
1. **2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors** – This invention focuses on 2,4-disubstituted pyrimidine compounds that serve as effective kinase inhibitors. The associated compositions and methods for their use offer valuable therapeutic avenues in treating various diseases.
2. **Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor** – This patent presents a salt form and related compositions that inhibit EGFR kinases, demonstrating desirable characteristics for therapeutic applications.
Career Highlights
Richland has played a vital role in several respected companies throughout his career, including Celgene and Avilomics Research, Inc. His expertise and innovative approach to pharmaceutical research have positioned him as a key figure in the development of effective medical therapies.
Collaborations
Throughout his career, Richland has collaborated with notable professionals, including Juswinder Singh and Russell Colyn Petter. These partnerships have enhanced the innovative processes and outcomes in his research endeavors.
Conclusion
Richland Wayne Tester continues to make significant strides in the field of pharmaceutical innovation through his patents and collaborations. His work in developing kinase inhibitors is paving the way for future advancements in targeted therapies, showcasing the lasting impact of his contributions to the medical community.